Investor Relations

IR Home

Stock Chart
VNDA (Common)
ExchangeNASDAQ (US Dollar)
Price$16.33
Change (%) Stock is Up 0.03 (0.18%)
Volume47,789
Data as of 08/17/17 11:16 a.m. ET
Minimum 20 minute delay
Refresh quote
August 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-2-1123
08/03/17
10-Q
Formats:  Excel HTML Adobe PDF Word XBRL
45
6789101112
13141516171819
20212223242526
27282930315152

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Recent News
08/02/17
Vanda Pharmaceuticals Reports Second Quarter 2017 Financial Results
07/21/17
Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of Schizophrenia
07/17/17
Vanda Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 2, 2017
More >>
Upcoming Events
There are currently no events scheduled.
More >>
Latest Presentation
Download Documentation JMP Securities 2017 Life Sciences Conference Presentation

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy